Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S. regulatory decision ...

The FDA said four major retailers continued to sell baby formula linked to a nationwide outbreak of bacterial illness in ...

President Donald Trump signed an executive order on Monday declaring fentanyl a weapon of mass destruction, a move that ...

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

In the study, a once-daily, single-tablet combination of bictegravir and lenacapavir was as effective as Gilead's existing ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of ...

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

The son of Hollywood actor and filmmaker Rob Reiner has been jailed as a suspect in the killing of his parents after they ...

U.S. President Donald Trump said on Monday he is considering an executive order to reclassify marijuana as a less dangerous ...

Belarusian President Alexander Lukashenko said in an interview with U.S. media organization Newsmax on Monday that Venezuelan ...

The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's treatment for a type of blood cancer, bringing the total number of products ...

Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning trade.